Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/cas.12734

http://scihub22266oqcxt.onion/10.1111/cas.12734
suck pdf from google scholar
C4582987!4582987 !26298849
unlimited free pdf from europmc26298849
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26298849 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid26298849
      Cancer+Sci 2015 ; 106 (9 ): 1182-7
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Susceptibility of pancreatic cancer stem cells to reprogramming #MMPMID26298849
  • Noguchi K ; Eguchi H ; Konno M ; Kawamoto K ; Nishida N ; Koseki J ; Wada H ; Marubashi S ; Nagano H ; Doki Y ; Mori M ; Ishii H
  • Cancer Sci 2015[Sep]; 106 (9 ): 1182-7 PMID26298849 show ga
  • Previous reports have indicated that reprogramming technologies may be useful for altering the malignant phenotype of cancer cells. Although somatic stem cells in normal tissues are more sensitive to reprogramming induction than differentiated cells, it remains to be elucidated whether any specific subpopulations are sensitive to reprogramming in heterogeneous tumor tissues. Here we examined the susceptibility of pancreatic cancer stem cells (CSC) and non-CSC to reprogramming. To characterize CSC populations, we focused on c-Met signaling, which has been identified as a marker of CSC in mouse experiments in vivo. Cells that expressed high levels of c-Met showed higher CSC properties, such as tumor-initiating capacity, and resistance to gemcitabine. Real-time reverse transcription-polymerase chain reaction in cells expressing high levels of c-Met revealed endogenous expression of reprogramming factors, such as OCT3/4, SOX2, KLF4 and cMYC. Introduction of these four factors resulted in higher alkaline phosphatase staining in cells with high c-Met expression than in controls. Therefore, the study results demonstrate that cellular reprogramming may be useful for extensive epigenetic modification of malignant features of pancreatic CSC.
  • |Cell Line, Tumor [MESH]
  • |Cellular Reprogramming/*physiology [MESH]
  • |Humans [MESH]
  • |Kruppel-Like Factor 4 [MESH]
  • |Kruppel-Like Transcription Factors/metabolism [MESH]
  • |Neoplastic Stem Cells/*metabolism/*physiology [MESH]
  • |Octamer Transcription Factor-3/metabolism [MESH]
  • |Pancreatic Neoplasms/*metabolism/*physiopathology [MESH]
  • |Proto-Oncogene Proteins c-met/metabolism [MESH]
  • |Proto-Oncogene Proteins c-myc/metabolism [MESH]
  • |SOXB1 Transcription Factors/metabolism [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box